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Co-morbidities associated with obstructive sleep apnea 
There are many co-morbid conditions that are associated with obstructive sleep apnea 
(OSA). Though a causative relationship between OSA and some of the co-morbidities 
is well established or strongly associated, many risk factors of OSA (age, male gender 
and obesity) are also known risk factors especially for cardiovascular diseases. Other 
important co-morbid conditions associated with OSA are neurocognitive dysfunction 
and, erectile dysfunction. Recently there are reports that ocular manifestations are 
associated with OSA. It is expected that more co-morbidities will be reported in OSA as 
the research in this area progresses. 
Key words: Co-morbidities in OSA, Hypertension, Cardiac arrhythmias, Stoke, 
Erectile dysfunction
Correspondence : Dr. V.K. Vijayan, 12, Lesly Villas, Karaparamba,  Kozhikode- 
673010, Kerala, E-mail: vijayanvk@hotmail.com.
V K Vijayan
Advisor to Director General, ICMR
Bhopal Memorial Hospital and Research Centre &
National Institute for Research in Environmental Health, Bhopal
ABSTRACT
Ann Natl Acad Med Sci (India), 49(3&4): 113-121, 2013
INTRODUCTION
OSA is the repetitive interruption 
of ventilation during sleep as a result of 
collapse of the pharyngeal airway. The 
most important co-morbidities associated 
with OSA are cardiovascular and 
c e r e b r o v a s c u l a r  d i s e a s e s ,  a n d 
neurocognitive dysfunction. The main 
cardiovascular morbidities reported in 
OSA are  sys temic  hyper tens ion , 
pulmonary hypertension,  cardiac 
arrhythmias, cardiovascular mortality, 
heart failure and stroke. Motor vehicle 
a c c i d e n t s  a r e  a l s o  i m p o r t a n t 
consequences in OSA (1).
OSA and cardiovascular diseases :
  OSA has been shown to increase 
the risk for systemic hypertension, 
pulmonary vascular disease, ischemic 
heart disease, cerebral vascular disease, 
congestive heart failure and arrhythmias 
(1, 2).  However, a causal relationship 
remains controversial.  Many risk factor 
of OSA (age, male gender and obesity) are 
also known risk factors for cardiovascular 
disease.  OSA is also associated with 
conditions (diabetic melli tus and 
hypertension) that are known to increase 
the risk for cardiovascular disease.  
Therefore, it is difﬁcult to prove whether 
OSA independently causes cardiovascular 
disease or not in these conditions.  
a) Systemic hypertension :
  In normal individuals, sleep is 
associated with a reduced blood pressure 
compared to wakefulness and this is 
known as “Dipping” phenomenon.  In 
normal individuals, systolic and diastolic 
blood pressure may decline as much as 10-
15%.  Sleep apnea has been found to blunt 
the dipping of blood pressure during 
sleep.  Disordered breathing during sleep 
has also been found to be associated with 
acute peripheral vasoconstriction and rise 
in blood pressure during sleep (3).  
Several studies have shown that OSA 
increases the relative risk of hypertension 
independent of other confounding factors.  
Sleep Heart Health Study (SHHS) in a 
cross sectional analysis of > 6000 patients 
has shown a linear relationship between 
systolic and diastolic blood pressure and 
OSA severity (4).  A Canadian population 
based study involving 2677 adults aged 
20-85 years, had shown that each apneic 
event per hour increased the odds of 
hypertension by 1% and each 10% 
reduction in nocturnal O  saturation 
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increased the likelihood of hypertension 
developing by 13%  (5).  As the above 
studies were cross sectional in nature 
linking sleep-disordered breathing to 
chronically elevated blood pressure, a 
prospective, population-based study was 
conducted to know the association 
between objectively measured sleep-
disordered breathing and hypertension 
(6). This Wisconsin sleep cohort study in 
709 participants had demonstrated a dose-
response association between sleep 
disordered breathing at baseline and the 
presence of hypertension four years later. 
This  was  independent  of  known 
compounding factors. Peppard et al found 
a dose-response association between 
sleep-disordered breathing at base line 
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and the presence of hypertension four 
years later that was independent of known 
confounding factors (6). This study 
suggested that sleep disordered breathing 
is likely to be a risk factor for hypertension 
and consequent cardiovascular morbidity 
in the general population (6).  In another 
prospective study of 2470 participants of 
SHHS aged > 40 years without baseline 
hypertension and not on antihypertensive 
medication, it has been shown that there is 
a signiﬁcant relationship between the risk 
of developing hypertension and OSA.   
However, this association was lost after 
adjustment for BMI.  A moderate 
inﬂuence of an AHI > 30 on hypertension 
could not be excluded in this study (7).  
Continuous positive airway pressure 
(CPAP) has been shown to acutely 
attenuate sympathetic drive and nocturnal 
BP in OSA (8).  Observational studies 
from uncontrolled and highly selected 
populations have suggested improvement 
in BP control with CPAP (9).  A meta- 
analysis of 12 placebo-controlled 
randomized trails (n = 572) found a 
statistically pooled reduction in mean BP 
of 1.69 mm Hg with CPAP treatment (10).  
Most of these trials were limited to 
normotensive individuals.  The seventh 
report of the Joint Committee on 
Prevention, Detection, Evaluation and 
Treatment of High Blood Pressure (JNC-
VII) has listed sleep apnea as a signiﬁcant 
cause of secondary hypertension (11).
b) Pulmonary hypertension : 
  Pulmonary hyper tension is 
deﬁned as a mean pulmonary arterial 
pressure>25 mm Hg at rest or >30 mm Hg 
w i t h  e x e r c i s e  a s  m e a s u r e d  b y              
right heart catheterization.  It has        
been  demons t ra ted  tha t  hypoxic 
vasoconstriction over time may result in 
pu lmonary  vascula r  remodel ing , 
contributing to the development of 
pulmonary hypertension, as seen in 
patients with chronic lung diseases.         
I t  m a y  t h e r e f o r e  b e  p o s s i b l e                  
that  repetitive upper airway collapse    
and oxyhemoglobin  desa tura t ion 
characteristic of OSA could also provide a 
pathophysiologic basis for elevations in 
pulmonary arterial pressure (12). Data 
from case series mainly in male patients 
have suggested that the prevalence of 
pulmonary hypertension in OSA varies 
from 17 to 53%.  However, there are no 
population based data to know the 
prevalence of pulmonary hypertension in 
OSA.  In a study of patients with OSA 
with no clinically signiﬁcant cardiac and 
pulmonary disease, 41% had pulmonary 
hypertension.  There was no difference in 
AHI, BMI, smoking history and lung 
function between patients with pulmonary 
hype r t ens ion  and  those  w i thou t 
pulmonary hypertension (13).  A placebo-
controlled randomized cross-over trial of 
CPAP and sham CPAP over 12 weeks has 
been reported in 23 patients with OSA and 
CPAP therapy reduced pulmonary arterial 
systemic pressure in all patients with 
pulmonary hypertension at baseline (14).  
The revised “Clinical Classiﬁcation of 
Pulmonary Hypertension” has identiﬁed 
sleep-disordered breathing as part of the 
category of respiratory disorders 
associated with pulmonary hypertension 
(15).
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c) Cardiac arrhythmias and 
cardiovascular mortality :
 The  preva lence  of  card iac 
a r r h y t h m i a s  i n  t w o  s a m p l e s  o f 
participants from the Sleep Heart Health 
study showed that compared with subjects 
with Respiratory Disturbance Index 
(RDI) < 5, those with severe OSA (RDI > 
30) had higher rates of atrial ﬁbrillation, 
non-sustained ventricular tachycardia, 
complex ventricular ectopy (bigeminy, 
t r i g e m i n y  a n d  q u a n d r i g e m i n y ) .  
Compared with those without sleep-
disordered breathing and adjusting for 
age, sex, body mass index, and prevalent 
coronary heart disease, individuals with 
sleep-disordered breathing had four times 
the odds of atrial ﬁbrillation (odds ratio 
[OR], 4.02), three times the odds of 
nonsustained ventricular tachycardia 
(OR, 3.40), and almost twice the odds of 
complex ventricular ectopy (OR, 1.74) 
(16). Bradyarrhythmias are also reported 
in OSA and can occur with a structurally 
normal heart. Effective CPAP therapy has 
b e e n  s h o w n  t o  a t t e n u a t e 
bradyarrhythmias (17).  People with 
sudden death from cardiac causes from 
midnight to 6 a.m. had a signiﬁcantly 
higher apnea-hypopnea index than those 
with sudden death from cardiac causes 
during other intervals. The relative risk of 
sudden death from cardiac causes from 
midnight to 6 a.m. was 2.57 for people 
with obstructive sleep apnea. In contrast, 
the risk of sudden death from cardiac 
causes in the general population peaks 
from 6 a.m. to noon and has a nadir from 
midnight to 6 a.m. (18). However, a 
causative role for sleep apnea in serious 
arrhythmias or sudden death has not been 
proven (16, 19).  In an observational study 
to compare incidence of fatal and non-
fatal cardiovascular events in simple 
snore rs ,  pa t i en t s  wi th  un t rea ted 
obstructive sleep apnoea-hypopnoea, 
patients treated with CPAP, and healthy 
men, it has been shown that severe 
obstructive sleep apnoea-hypopnoea 
signiﬁcantly increases the risk of fatal and 
non-fatal cardiovascular events in men 
and CPAP treatment reduces this risk (20). 
In an observational study, it has been 
reported severe OSA is associated with 
cardiovascular death in Women as well, 
and adequate CPAP treatment may reduce 
this risk (21).
d) OSA and heart failure :
  There is a close link between OSA 
and heart failure by their close association 
with aging and obesity.  The Framingham 
study had shown that increasing BMI is 
directly correlated with incident heart 
failure and may be mediated in part by 
OSA. Incident atrial ﬁbrillation, an 
important risk factor for heart failure is 
also associated with the degree of 
oxyhemoglobin desaturation in OSA (22-
24). Repetitive upper airway closure in 
OSA can have deleterious effects on 
cardiac function. In a study of subjects 
randomly assigned to receive medical 
therapy either alone or with the addition of 
continuous positive airway pressure for 
one month, it has been shown that 
treatment of coexisting obstructive sleep 
apnea by continuous positive airway 
pressure reduces systolic blood pressure 
and improves left ventricular systolic 
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function in medically treated patients with 
heart failure  (25). In another randomized 
study of patients with congestive heart 
failure and OSA receiving 3 months of 
CPAP, it has been shown that there is 
s igniﬁcant  improvements  in  le f t 
ventricular ejection fraction (LVEF) and 
reductions in urinary catecholamines, but 
no changes in BP (26). However in 
another rigorous, placebo-controlled 
cross-over study sing auto-titrating CPAP, 
Authors found no improvement in any 
parameter of cardio-vascular function, 
including left ventricular ejection 
fraction, blood pressure and exercise 
tolerance (27). Further trials are required 
to know the exact role of CPAP in patients 
with heart failure and OSA. High 
sensitivity troponin T (hs-TnT) levels 
have been shown to be predictor of 
coronary artery disease and heart failure 
(28). In a study of 1645 participants from 
Atherosclerosis Risk in Community 
(ARIC) and Sleep Heart Health Study 
(SHHS), it has been observed that there is 
an association between severity of OSA 
and high levels of hs-TnT suggesting that 
subclinical myocardial injury caused by 
OSA may play a role in subsequent risk of 
heart failure (28).
e) OSA and incident stroke :
  The incidence of stroke was 
studied in a geographically diverse, 
community based sample of male and 
female participants in SHHS.  Based on 8 
years of prospective data from the study, it 
has been observed that modest to severe 
levels of sleep apnea are associated with 
an approximately three-fold increased 
risk of ischemic stroke in men (29). A 
prospective study had shown that self-
reported snoring was an independent risk 
factor for stroke in women (30). Data from 
the  Wisconsin  Sleep Cohor t  had 
demonstrated that moderate to severe 
sleep-disordered breathing is a risk factor 
for prevalent stroke and that the 
preexisting sleep disorder may be a risk 
f ac to r  f o r  i nc iden t  s t r oke  (31 ) . 
Longitudinal data with a mean follow-up 
of 3.4 yr on mortality from stroke and 
other causes in patients with preexisting 
OSA, it has been shown that there is an 
increasing risk of events with OSA 
severity (32). It is feasible that stroke may 
itself predispose to sleep-disordered 
breathing. The strong association with 
atrial ﬁbrillation may confer a heightened 
risk of embolic events. OSA has been 
shown to promote thrombosis and doppler 
measurements have suggested that apneic 
events are associated with reduced 
cerebral blood ﬂow (33).
f) Erectile dysfunction :
A high prevalence of erectile 
dysfunction in OSA patients has been 
reported (34). It has been suggested that 
the nocturnal oxygen saturation observed 
in OSA may be an important factor 
contributing for the occurrence of OSA 
(34). Treatment with nasal CPAP has been 
found to resolve erectile dysfunction 
resulting in improvement in quality of life 
(35). 
g) Aortic aneurysm :
Abdominal aortic aneurysm has 
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been found to be highly prevalent in OSA 
and it has been reported that there was 
further expansion of abdominal aortic 
aneurysm in patients with severe OSA 
(36). 
Ocular manifestations :
R e c e n t l y  r e p o r t e d  o c u l a r 
manifestations in OSA are ﬂoppy eyelid 
syndrome (FES), glaucoma, papilledema, 
non-arteritic anterior ischemic optic 
neuropathy and retinal vein occlusion 
(37). Papillary conjunctivitis and a 
rubbery, redundant upper eyelid tissue is 
the characteristic features of FES and 
frequently manifests unilaterally affecting 
the eyelid on the side the patient most 
often sleeps on. Although the speciﬁc 
etiology of this association is not well 
described, one proposed mechanism 
suggests. It has been suggested that 
damage to the optic nerve head caused by 
apnea-induced ischemic events may be 
responsible for glaucoma in OSA patients, 
as it has been reported that glaucoma 
severi ty correlates with both the 
frequency and duration of apnoeic 
episodes. There is forced inspiration 
against a closed airway in OSA and this 
can lead to an increase in venous pressures 
and impaired venous return with 
subsequent increase in intracranial 
pressure resulting in papilledema. 
Papilledema can also result  from 
hypercapnea which has been reported to 
occur in OSA. Though the mechanism of 
nonarteritic ischemic optic neuropathy is 
not well understood, it is possible that 
intermittent apnea-induced increases in 
blood pressure and intracranial pressure 
and nocturnal hypoxemia may result in 
optic nerve edema leading to optic 
neuropathy. Retinal vein occlusion in 
patients with OSA may be to the 
consequences of impaired venous return 
of the retina and atherosclerotic defects of 
the feeding arterioles. 
Other medical consequences :
  Other medical consequences of 
OSA inc lude  excess ive  day t ime 
sleepiness, loss of alertness, memory 
deﬁcit, reduced vigilance, impaired 
executive function, increased risk for 
automobile and occupational accidents 
and decreased quality of life (38).
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